Clinical Trials Browser

Terminated × Immunoglobulin Light-chain Amyloidosis × Bortezomib × Clear all

NCT01728259 2023-05-09

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Phase 1 Terminated

Immunoglobulin Light-chain Amyloidosis

NCT02489500 2018-09-10

VelRand

Phase 3 Terminated

3 enrolled 11 charts

Immunoglobulin Light-chain Amyloidosis